RA Capital Management’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,007,946
| Closed | -$30.8M | – | 70 |
|
|
2023
Q3 | $30.8M | Hold |
2,007,946
| – | – | 0.61% | 41 |
|
|
2023
Q2 | $47.8M | Hold |
2,007,946
| – | – | 0.9% | 32 |
|
|
2023
Q1 | $51.1M | Buy |
2,007,946
+1,127,946
| +128% | +$28.7M | 1.16% | 28 |
|
|
2022
Q4 | $25.7M | Hold |
880,000
| – | – | 0.52% | 43 |
|
|
2022
Q3 | $18M | Buy |
+880,000
| New | +$18M | 0.39% | 53 |
|
|
2021
Q4 | – | Sell |
-1,034
| Closed | -$17K | – | 102 |
|
|
2021
Q3 | $17K | Sell |
1,034
-311,294
| -100% | -$5.12M | ﹤0.01% | 95 |
|
|
2021
Q2 | $5.71M | Hold |
312,328
| – | – | 0.09% | 85 |
|
|
2021
Q1 | $5.22M | Sell |
312,328
-139,604
| -31% | -$2.33M | 0.08% | 79 |
|
|
2020
Q4 | $7.43M | Buy |
+451,932
| New | +$7.43M | 0.1% | 77 |
|